Clinical trial
DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery
NCT00387829 · Integra LifeSciences Corporation, Industry · Terminated
Key facts
| NCT number | NCT00387829 |
|---|---|
| Title | DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery |
| Official title | Randomized Controlled Trial of DuraGen Plus® Adhesion Barrier Matrix to Minimize Adhesions Following Lumbar Discectomy |
| Lead sponsor | Integra LifeSciences Corporation, Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Spinal Injuries, Adhesions |
| Intervention type | Device |
| Interventions | DuraGen Plus Adhesion Barrier Matrix |
| Enrollment | 347 |
| Start date | Oct 1, 2006 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2011 |
| First posted | Oct 13, 2006 |
| Last update posted | Sep 7, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- 10–99 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: